Analysts think OCGN stock price could increase by 387%
Jul 31, 2024, 6:27 AM
-13.31%
What does OCGN do
Ocugen, Inc., a biopharmaceutical company based in Malvern, Pennsylvania, specializes in therapies for eye diseases and vaccines, including a COVID-19 vaccine candidate for North America. Founded in 2014, the company employs 84 people and is developing platforms for gene and cell therapy, biologics, and mucosal vaccines.
5 analysts think OCGN stock price will increase by 387.37%. The current median analyst target is $7.14 compared to a current stock price of $1.47. The lowest analysts target is $5.05 and the highest analyst target is $8.40.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
